Blumenfeld S Morry 4
4 · MAKO Surgical Corp. · Filed Mar 28, 2012
Insider Transaction Report
Form 4
Blumenfeld S Morry
Director
Transactions
- Sale
Common Stock
2012-03-26$45.00/sh−8,513$383,085→ 483,435 total(indirect: By Ziegler Meditech Equity Partners, L.P.) - Sale
Common Stock
2012-03-27$45.00/sh−24,630$1,108,382→ 458,805 total(indirect: By Ziegler Meditech Equity Partners, L.P.)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ziegler Meditech Equity Partners, L.P. on November 11, 2011.
- [F2]The reporting person is a member of the board of managers of Ziegler Meditech Partners, LLC, the general partner of Ziegler Meditech Equity Partners, L.P., but he disclaims beneficial ownerhsip of the shares except to the extent of his pecuniary interest therein.
- [F3]The price in column 4 is a weighted average price per share. The prices actually paid ranged from $45.00 to $45.01 per share. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.